Novel sulfonamide series of qr2 inhibitors to tackle oxidative stress and cognitive decline
Номер патента: EP4313031A1
Опубликовано: 07-02-2024
Автор(ы): Efrat EDRI, Kobi ROSENBLUM, Natheniel GOULD
Принадлежит: Carmel Haifa University Economic Corp Ltd
Опубликовано: 07-02-2024
Автор(ы): Efrat EDRI, Kobi ROSENBLUM, Natheniel GOULD
Принадлежит: Carmel Haifa University Economic Corp Ltd
Реферат: The present invention provides an aromatic sulfonamide -based compound, a pharmaceutical composition comprising same, and methods of using same, such as for inhibiting quinone reductase 2 (QR2) or treating a QR2-related disease or disorder.
Novel sulfonamide series of qr2 inhibitors to tackle oxidative stress and cognitive decline
Номер патента: IL307326A. Автор: Kobi ROSENBLUM,Natheniel GOULD,Efrat EDRI. Владелец: Efrat EDRI. Дата публикации: 2023-11-01.